EyeYon
EyeYon Medical is an Israeli start-up company that develops innovative medical devices for the treatment of corneal edema. EyeYon Medical was founded by Dr. Daphna Ofer, a senior ophthalmologist, Dr. Arie Marcovich, a senior cornea surgeon, and Nahum Ferera, an experienced business executive. The company operates within the Van Leer Technology Incubator.
EyeYon Medical is an Israeli start-up company that develops innovative medical devices for the treatment of corneal edema. EyeYon Medical was founded by Dr. Daphna Ofer, a senior ophthalmologist, Dr. Arie Marcovich, a senior cornea surgeon, and Nahum Ferera, an experienced business executive. The company operates within the Van Leer Technology Incubator.
EyeYon has raised $25.0M across 1 round. Its most recent round was a Series C of $25.0M in Mar 2021. Full funding history, investors, and team are detailed below.
Funding history
1 round on record.
Unlock the lead investor and full details for this round.
People
Founders, executives, and decision-makers — sourced and refreshed weekly.
See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.
EyeYon is featured in
Similar companies
Inspira Technologies is a cutting-edge medical technology company that specializes in the acute respiratory care sector. Their unique ART technology aims to meet the demand for treatment that supports patients with acute respiratory conditions without the need for mechanical ventilation while they are conscious and breathing independently.
Alpha Tau Medical is an Israeli medical device company that focuses on research, development and commercialization of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid cancer. The Alpha DaRT technology was developed in 2003 at Tel Aviv University. Since then, numerous preclinical trials have found the technology to be effective and safe for various indications and anatomic areas. The findings were published in 12 papers in peer-reviewed scientific journals. Today, the company is running its first clinical trial with very promising preliminary results.
Adenocyte is a privately held medical technology business that focuses on early diagnosis of adenocarcinoma and its precancerous precursor.
Vortex Imaging develops medical imaging devices.
Urologic Health developing innovative solutions to improve bladder function diagnosis, monitoring, and treatment of urinary disorders.
VISIONIX develops, manufactures and distributes innovative equipment and provides a complete solution for ophthalmologists, optometrists, opticians and optical laboratories. VISIONIX developed its products by relying on its innovative patented PowerMap TM technology, which provides simultaneous multipoint measurements of all the parameters of a lens. The technology, originated by the impressive list of VISIONIX scientists, is based on Hartman Wavefront 3-D technology. Visionix is partnered with Briot since 2010.
Fize Medical is a health care company based in Israel.
Synchrony Medical is a clinical stage medical device company developing LibAirty, a next generation, home-use, airway clearance system designed to help patients with chronic lung disease such as COPD and CF maintain clear lungs with a short, daily, proficient treatment.
TopGum has developed a highly scalable patent-pending delivery system with the capacity to deliver a wide range of nutrients and API, manufactured to the highest health and safety standards.
Nanox offers the Nanox System as a preventative healthcare Medical Screening As A Service (MSaaS). Nanox field-effect cathode technology was originally developed for use in high-definition flat panel displays. Over time, the manufacturing processes were ported from glass to silicon, enabling enormous increases in power density and uniformity. After more than 20 years of research and development, with over $1B invested, their team of engineers has developed unique intellectual property, patents, and capability to design and build high-powered field-effect cathodes that outperform all previous efforts. Nanox’s proprietary cold cathode technology greatly expands the capabilities of X-ray imaging. At the core of their high-powered cold cathode is a “chip” of nano-scale structures created using proprietary nanofabrication techniques. The chip is designed to support various use cases of medical imaging and will be supported by peripheral technologies in order to translate their benefits into various real-world applications.
QuantHealth is an organization that produces software using artificial intelligence technology for drug development data. This software is utilized for conducting patient-focused medication simulations, with the aim of expediting and reducing the risks associated with drug development. By merging data from various sources within clinical and drug development fields, the company's software can forecast how patients will respond to both existing and innovative treatments. This enables pharmaceutical and biotechnology clients to conduct different versions of their clinical trials, enhancing trial design and boosting the chances of successful trials. As a result, QuantHealth aids in uncovering new clinical prospects and optimization strategies.
Microbot Medical is a company that creates innovative medical devices using micro-robotic technology. They are dedicated to improving surgical outcomes for patients by allowing more physicians to treat more patients. Currently, they are working on the development of two products: the Self Cleaning Shunt for hydrocephalus treatment and the TipCAT endoscope for colonoscopy procedures.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.